{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:36:03Z","timestamp":1785544563359,"version":"3.56.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Aplastic anemia (AA) rarely coexists with intestinal Beh\u00e7et disease (iBD), and the post-partum period may further complicate its expression. Managing refractory iBD with recurrent perforation on a background of long-standing AA is challenging, and evidence on optimal treatment is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 42-year-old woman with non-severe aplastic anemia (NSAA) diagnosed in 2005 (AA duration\u2005\u2248\u200520 years) developed recurrent fever, oral ulcers, and penetrating ulcers of the ileocaecum and terminal ileum shortly after cesarean delivery in June 2019, with one episode of vulvar ulceration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Histology showed transmural vasculitis with focal obliterative endarteritis, confirming iBD; HLA-B51 was negative. Pre-transplant marrow was markedly hypocellular without dysplasia, and karyotype (46,XX), flow cytometry, myelodysplastic syndrome\/AML and myeloproliferative neoplasm gene panels, and paroxysmal nocturnal hemoglobinuria screening were all negative, supporting acquired AA rather than hypoplastic myelodysplastic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Despite corticosteroids, tacrolimus, tofacitinib, and tocilizumab, she sustained 2 intestinal perforations (May and September, 2023). As iBD was refractory and AA had progressed to very severe AA, she underwent human leukocyte antigen (HLA)-matched sibling peripheral-blood allogeneic hematopoietic stem cell transplantation (allo-HSCT) in June 2024 with fludarabine\/busulfan\/cyclophosphamide\/ anti-thymocyte globulin conditioning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>\n                      Neutrophil and platelet engraftment occurred around D+11 and D+15, with 100% donor chimerism at D+16 and no acute or chronic graft-versus-host disease; only transient, self-limiting cytomegalovirus (CMV) and Epstein\u2013Barr virus DNAemia occurred, without CMV disease or post-transplant lymphoproliferative disorder. Blood counts recovered progressively, with hemoglobin 127 grams\/L and platelets 118\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L at the last follow-up (\u224812 months), only mild residual cytopenia, transfusion independence, and sustained remission of iBD on maintenance immunosuppression. She then returned to work and was lost to follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case suggests that allo-HSCT may be an effective option for selected patients with AA and refractory iBD, achieving sustained remission of both the marrow failure and the intestinal disease. As this is a single case with limited follow-up (\u224812 months), longer follow-up and additional cases are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049997","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:28:44Z","timestamp":1785533324000},"page":"e49997","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Allogeneic haematopoietic stem cell transplantation for refractory perforating intestinal Beh\u00e7et disease in a patient with aplastic anaemia: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2804-5333","authenticated-orcid":false,"given":"Xiuyun","family":"Rao","sequence":"first","affiliation":[{"name":"Guizhou Provincial Key Laboratory for Digestive System Diseases, Guizhou Medical University and Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Luo","sequence":"additional","affiliation":[{"name":"Guizhou Provincial Key Laboratory for Digestive System Diseases, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Dai","sequence":"additional","affiliation":[{"name":"Guizhou Provincial Key Laboratory for Digestive System Diseases, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0539-4818","authenticated-orcid":false,"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Guizhou Provincial Key Laboratory for Digestive System Diseases, Guizhou Medical University and Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260731","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia.","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"key":"R2-20260731","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3389\/fonc.2018.00587","article-title":"Pathogenesis of acquired aplastic anemia and the role of the bone marrow microenvironment.","volume":"8","author":"Medinger","year":"2018","journal-title":"Front Oncol"},{"key":"R3-20260731","doi-asserted-by":"crossref","first-page":"110036","DOI":"10.1016\/j.intimp.2023.110036","article-title":"Autoimmune pathogenesis, immunosuppressive therapy and pharmacological mechanism in aplastic anemia.","volume":"117","author":"Pan","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R4-20260731","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3324\/haematol.2017.169862","article-title":"Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000\u20132011.","volume":"102","author":"Vaht","year":"2017","journal-title":"Haematologica"},{"key":"R5-20260731","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-20260731","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10620-008-0337-4","article-title":"Gastrointestinal manifestations of Beh\u00e7et\u2019s disease.","volume":"54","author":"Ebert","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R7-20260731","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3349\/ymj.2016.57.1.22","article-title":"Intestinal Beh\u00e7et\u2019s disease: a true inflammatory bowel disease or merely an intestinal complication of systemic vasculitis?","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"key":"R8-20260731","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00054725-200108000-00010","article-title":"Colonoscopic findings in intestinal Beh\u00e7et\u2019s disease.","volume":"7","author":"Lee","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"R9-20260731","doi-asserted-by":"crossref","first-page":"e3348","DOI":"10.1097\/MD.0000000000003348","article-title":"Clinical characteristics, treatment, and long-term outcome of gastrointestinal involvement in Beh\u00e7et\u2019s syndrome.","volume":"95","author":"Hatemi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R10-20260731","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/rheumatology\/ken162","article-title":"Beh\u00e7et\u2019s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8.","volume":"47","author":"Ahn","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R11-20260731","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1080\/10428194.2018.1542152","article-title":"Gastrointestinal Beh\u00e7et\u2019s-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review.","volume":"60","author":"Wesner","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"R12-20260731","doi-asserted-by":"crossref","first-page":"e17979","DOI":"10.1097\/MD.0000000000017979","article-title":"Intestinal Beh\u00e7et disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: a case report.","volume":"98","author":"Asano","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R13-20260731","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13023-025-03878-y","article-title":"Clinical features and novel pathogenic variants of patients with Beh\u00e7et\u2019s disease like trisomy 8.","volume":"20","author":"Ding","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"R14-20260731","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood-2007-01-066258","article-title":"Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia.","volume":"110","author":"Solomou","year":"2007","journal-title":"Blood"},{"key":"R15-20260731","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/gene.2014.64","article-title":"Activation of the JAK\/STAT pathway in Beh\u00e7et\u2019s disease.","volume":"16","author":"Tulunay","year":"2015","journal-title":"Genes Immun"},{"issue":"4 Suppl 67","key":"R16-20260731","first-page":"S71","article-title":"Th17 cells in Beh\u00e7et\u2019s disease: a new immunoregulatory axis.","volume":"29","author":"Hamzaoui","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R17-20260731","doi-asserted-by":"crossref","first-page":"151956","DOI":"10.1016\/j.semarthrit.2022.151956","article-title":"Immunopathogenesis of Beh\u00e7et\u2019s disease and treatment modalities.","volume":"52","author":"van der Houwen","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"R18-20260731","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00535-020-01690-y","article-title":"Evidence-based diagnosis and clinical practice guidelines for intestinal Beh\u00e7et\u2019s disease 2020.","volume":"55","author":"Watanabe","year":"2020","journal-title":"J Gastroenterol"},{"key":"R19-20260731","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0000000000000125","article-title":"An update on the diagnosis, treatment, and prognosis of intestinal Beh\u00e7et\u2019s disease.","volume":"27","author":"Cheon","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"R20-20260731","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4078\/jrd.2021.28.1.4","article-title":"Advances in management of intestinal Beh\u00e7et\u2019s disease: a perspective from gastroenterologists.","volume":"28","author":"Cheon","year":"2021","journal-title":"J Rheum Dis"},{"key":"R21-20260731","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome.","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R22-20260731","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.semarthrit.2020.05.017","article-title":"Effectiveness of tocilizumab in Beh\u00e7et\u2019s disease: a systematic literature review.","volume":"50","author":"Akiyama","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R23-20260731","first-page":"958","article-title":"Advance in hematopoietic and immune reconstitution of allogeneic stem cell transplantation.","volume":"41","author":"Huo","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R24-20260731","doi-asserted-by":"crossref","first-page":"e39302","DOI":"10.1016\/j.heliyon.2024.e39302","article-title":"Advances in hematopoietic stem cell transplantation for autoimmune diseases.","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"key":"R25-20260731","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"R26-20260731","first-page":"100278","article-title":"Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Beh\u00e7et-like disease.","volume":"16","author":"Ishii","year":"2021","journal-title":"Leuk Res Rep"},{"key":"R27-20260731","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1399-0039.2007.00932.x","article-title":"HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.","volume":"70","author":"Trachtenberg","year":"2007","journal-title":"Tissue Antigens"},{"key":"R28-20260731","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/tan.12003","article-title":"The HLA-B gene and Hashimoto disease in Han Chinese children: a case-control and family-based study.","volume":"80","author":"Huang","year":"2012","journal-title":"Tissue Antigens"},{"key":"R29-20260731","doi-asserted-by":"crossref","first-page":"e0281698","DOI":"10.1371\/journal.pone.0281698","article-title":"Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population.","volume":"19","author":"Li","year":"2024","journal-title":"PLoS One"},{"key":"R30-20260731","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00277-020-03951-5","article-title":"How to treat myelodysplastic syndrome with clinical features resembling Beh\u00e7et syndrome: a case-based systematic review.","volume":"99","author":"Yilmaz","year":"2020","journal-title":"Ann Hematol"},{"key":"R31-20260731","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2012.07.008","article-title":"Host remodeling of the gut microbiome and metabolic changes during pregnancy.","volume":"150","author":"Koren","year":"2012","journal-title":"Cell"},{"key":"R32-20260731","doi-asserted-by":"crossref","first-page":"102651","DOI":"10.1016\/j.jaut.2021.102651","article-title":"T helper cell immunity in pregnancy and influence on autoimmune disease progression.","volume":"121","author":"Graham","year":"2021","journal-title":"J Autoimmun"},{"key":"R33-20260731","doi-asserted-by":"crossref","first-page":"102468","DOI":"10.1016\/j.autrev.2020.102468","article-title":"Estrogen, estrogen-like molecules and autoimmune diseases.","volume":"19","author":"Merrheim","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R34-20260731","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-023-00864-2","article-title":"The maternal gut microbiome in pregnancy: implications for the developing immune system.","volume":"21","author":"Koren","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R35-20260731","doi-asserted-by":"crossref","first-page":"960208","DOI":"10.3389\/fcimb.2022.960208","article-title":"Human umbilical cord mesenchymal stem cells regulate immunoglobulin A secretion and remodel the diversification of intestinal microbiota to improve colitis.","volume":"12","author":"Liu","year":"2022","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:28:50Z","timestamp":1785533330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":35,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049997","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"2026-01-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}